USPTO serial 97065557
SYNAPSE MED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 29, 2025
- Examiner
- LE, KIEU-NHI NGOC
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SYNAPSE MED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Todd A. Denys
Todd A. Denys Mandelbaum Barrett PC3 Becker Farm Road, Suite 105Roseland, NJ 07068United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software using artificial intelligence for medical prescription assistance, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence to avoid medical risks and contraindications and for drug interaction prevention, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence for medical prescriptions analysis, namely, software for word processing and establishing standardized directories; none of the above products are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field | ACTIVE | — |
| 042 | Research in the field of artificial intelligence for computer software design for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Research in the field of artificial intelligence for computer software design for prescription analysis; Software design and development for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software design and development for prescription analysis; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories in the fields of medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories for prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field; Software as a service (SAAS) services featuring software modules for providing prescription assistance through telemedicine platforms | ACTIVE | — |
| 044 | Telemedicine services; Prescription assistance modules in the nature of providing information in the field of medical prescriptions via telemedicine platforms; Providing advice relating to medical services provided via telecommunications technology; providing information in the field of telemedicine; providing information in the field of medical prescription; providing information in the field of medical prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SYNAPSE MEDICINE
- Other trademarks owned by SYNAPSE MEDICINE
- Other trademarks owned by SYNAPSE MEDICINE
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SYNAPSE MED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 29, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 29, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 16, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 16, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 16, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 16, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 7, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 7, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 3, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 10, 2025 | IUAF | USE AMENDMENT FILED | — |
| Mar 10, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 10, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 7, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 6, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2024 | ALIE | ASSIGNED TO LIE | — |
| Apr 17, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 17, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 17, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 17, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 17, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 17, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 14, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 14, 2023 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 14, 2023 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 14, 2023 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 16, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 16, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 16, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 1, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 12, 2021 | NWAP | NEW APPLICATION ENTERED | — |